Erythropoietin to Enhance Recovery of Erectile Function in Men Following Radical Prostatectomy: The ERECT Trial

Hiten D. Patel, Mohamad E. Allaf

Research output: Contribution to journalComment/debatepeer-review

Abstract

Erythropoietin receptors have been localized to human penile tissue and periprostatic neurovascular bundles. ERECT is a placebo-controlled, phase 2, randomized trial assessing the effect of erythropoietin on recovery of erectile function for men undergoing radical prostatectomy for prostate cancer.

Original languageEnglish (US)
Pages (from-to)698-699
Number of pages2
JournalEuropean Urology Focus
Volume5
Issue number4
DOIs
StatePublished - Jul 2019

ASJC Scopus subject areas

  • Urology

Fingerprint

Dive into the research topics of 'Erythropoietin to Enhance Recovery of Erectile Function in Men Following Radical Prostatectomy: The ERECT Trial'. Together they form a unique fingerprint.

Cite this